Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shin Kariya

Showing results (141-150 of 144) with videos related to

Pageof 15
Sort By:
You have reached the last page of results.This site can display upto 144 results.
Allergology International : Official Journal of the Japanese Society of Allergology|January 19, 2020
Serum IgG4 as a biomarker reflecting pathophysiology and post-operative recurrence in chronic rhinosinusitisAiko Oka, Takahiro Ninomiya, Tazuko Fujiwara, et al.
International Journal of Clinical Oncology|November 13, 2021
Outcomes of long-term nivolumab and subsequent chemotherapy in Japanese patients with head and neck cancer: 2-year follow-up from a multicenter real-world studyRyuji Yasumatsu, Yasushi Shimizu, Nobuhiro Hanai, et al.
International Journal of Clinical Oncology|April 8, 2021
Effectiveness of nivolumab affected by prior cetuximab use and neck dissection in Japanese patients with recurrent or metastatic head and neck cancer: results from a retrospective observational study in a real-world settingShin Kariya, Yasushi Shimizu, Nobuhiro Hanai, et al.
International Journal of Clinical Oncology|November 21, 2020
Effectiveness and safety of nivolumab in patients with head and neck cancer in Japanese real-world clinical practice: a multicenter retrospective clinical studyNobuhiro Hanai, Yasushi Shimizu, Shin Kariya, et al.
Pageof 15

Showing results (141-150 of 144) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 144 results.
Allergology International : Official Journal of the Japanese Society of Allergology|January 19, 2020
Serum IgG4 as a biomarker reflecting pathophysiology and post-operative recurrence in chronic rhinosinusitisAiko Oka, Takahiro Ninomiya, Tazuko Fujiwara, et al.
International Journal of Clinical Oncology|November 13, 2021
Outcomes of long-term nivolumab and subsequent chemotherapy in Japanese patients with head and neck cancer: 2-year follow-up from a multicenter real-world studyRyuji Yasumatsu, Yasushi Shimizu, Nobuhiro Hanai, et al.
International Journal of Clinical Oncology|April 8, 2021
Effectiveness of nivolumab affected by prior cetuximab use and neck dissection in Japanese patients with recurrent or metastatic head and neck cancer: results from a retrospective observational study in a real-world settingShin Kariya, Yasushi Shimizu, Nobuhiro Hanai, et al.
International Journal of Clinical Oncology|November 21, 2020
Effectiveness and safety of nivolumab in patients with head and neck cancer in Japanese real-world clinical practice: a multicenter retrospective clinical studyNobuhiro Hanai, Yasushi Shimizu, Shin Kariya, et al.
Pageof 15